1. Home
  2. LTRY vs IMCC Comparison

LTRY vs IMCC Comparison

Compare LTRY & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRY
  • IMCC
  • Stock Information
  • Founded
  • LTRY 2015
  • IMCC 1980
  • Country
  • LTRY United States
  • IMCC Israel
  • Employees
  • LTRY N/A
  • IMCC N/A
  • Industry
  • LTRY Computer Software: Prepackaged Software
  • IMCC Medicinal Chemicals and Botanical Products
  • Sector
  • LTRY Technology
  • IMCC Health Care
  • Exchange
  • LTRY Nasdaq
  • IMCC Nasdaq
  • Market Cap
  • LTRY N/A
  • IMCC 10.0M
  • IPO Year
  • LTRY N/A
  • IMCC N/A
  • Fundamental
  • Price
  • LTRY $1.31
  • IMCC $3.37
  • Analyst Decision
  • LTRY
  • IMCC
  • Analyst Count
  • LTRY 0
  • IMCC 0
  • Target Price
  • LTRY N/A
  • IMCC N/A
  • AVG Volume (30 Days)
  • LTRY 1.1M
  • IMCC 146.8K
  • Earning Date
  • LTRY 08-18-2025
  • IMCC 08-13-2025
  • Dividend Yield
  • LTRY N/A
  • IMCC N/A
  • EPS Growth
  • LTRY N/A
  • IMCC N/A
  • EPS
  • LTRY N/A
  • IMCC N/A
  • Revenue
  • LTRY $1,030,318.00
  • IMCC $37,894,737.00
  • Revenue This Year
  • LTRY N/A
  • IMCC $47.12
  • Revenue Next Year
  • LTRY N/A
  • IMCC $12.83
  • P/E Ratio
  • LTRY N/A
  • IMCC N/A
  • Revenue Growth
  • LTRY N/A
  • IMCC 12.68
  • 52 Week Low
  • LTRY $0.22
  • IMCC $1.29
  • 52 Week High
  • LTRY $2.65
  • IMCC $7.12
  • Technical
  • Relative Strength Index (RSI)
  • LTRY 53.23
  • IMCC 60.91
  • Support Level
  • LTRY $1.27
  • IMCC $2.37
  • Resistance Level
  • LTRY $1.38
  • IMCC $3.50
  • Average True Range (ATR)
  • LTRY 0.11
  • IMCC 0.38
  • MACD
  • LTRY 0.01
  • IMCC 0.05
  • Stochastic Oscillator
  • LTRY 77.14
  • IMCC 84.73

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: